期刊
IMMUNOLOGICAL REVIEWS
卷 275, 期 1, 页码 79-88出版社
WILEY
DOI: 10.1111/imr.12508
关键词
AIDS; autoantibodies; autoimmunity; B cells; vaccination
类别
资金
- NIH
- Bill and Melinda Gates Foundation
- NIAID UM1 Center for HIV/AIDS Vaccine Immunology Immunogen Discovery award [AI100645]
Induction of broadly neutralizing antibodies (bNAbs) is a major goal of HIV vaccine development. BNAbs are made during HIV infection by a subset of individuals but currently cannot be induced in the setting of vaccination. Considerable progress has been made recently in understanding host immunologic controls of bNAb induction and maturation in the setting of HIV infection, and point to key roles for both central and peripheral immunologic tolerance mechanisms in limiting bnAb development. Immune tolerance checkpoint inhibition has been transformative in promotion of anti-tumor CD8 T-cell responses in the treatment of certain malignancies. Here, we review the evidence for host controls of bNAb responses, and discuss strategies for the transient modulation of immune responses with vaccines toward the goal of enhancing germinal center B-cell responses to favor bNAb B-cell lineages and to foster their maturation to full neutralization potency.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据